Mirum Pharmaceuticals Inc To Discuss The Topline Data From the MARCH Study Call Transcript
Hello, and a warm welcome to the Mirum Phase III Top Line Results Conference Call. My name is Candice, and I'll be your moderator for today's call. (Operator Instructions)
I would now like to pass you over to our host for today's call, Ian Clements, CFO. Please go ahead.
Thanks, Candice, and good morning, everyone. I'd like to welcome you to Mirum's MARCH-PFIC Phase III top line results conference call. I'm joined today by President and CEO, Chris Peetz; Head of R&D, Pam Vig, Chief Development Officer, Lara Longpre; and Chief Operating Officer, Peter Radovich. Earlier this morning, Mirum issued a news release announcing positive results from our Phase III MARCH study. Copies of the news release can be found in the IR section of our website. Also in the IR section of our website, you can find a slide deck outlining results in this study. We will refer to this deck as we go through the results this morning.
Before we begin, I'd like to remind you that during the course of this conference call,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |